Skip to main content
. 2022 Jun 9;9(6):3846–3857. doi: 10.1002/ehf2.14009

Figure 3.

Figure 3

Continuous hazard ratios across TMAO for major adverse cardiac events (A), all‐cause death (B), myocardial infarction (C), and rehospitalization due to heart failure (D). HR, hazard ratio; TMAO, trimethylamine‐N‐oxide.